Health Care Deal News, April 1, 2013 - February Saw a Good Bit of M&A Activity with Some Sizable Prices, Hepatitis C Doesn’t Excite Anyone Except Investors


Brought to you by

April 1, 2013 Issue:


Recent Health Care M&A Deals





Prospect Medical Holdings

CharterCare Health Partners






Shire US Holdings Inc.

SARcode Bioscience Inc.

$160 million

BioDelivery Sciences International, Inc.

Topical Clonidine Gel

$2 million

Clinigen Group plc


$33 million





American Family Care, Inc.

Doctors Express



Service Deal of the Week
HealthLease Properties REIT (TSX: HLP.UN), an affiliate of Mainstreet Property Group, is scooping up 13 senior housing and senior care properties in North Carolina, Pennsylvania and Virginia, for approximately $141.7 million. The deal includes four skilled nursing facilities, with a total of 355 units, eight combination assisted living/memory care facilities with 563 units, and one standalone memory care facility, with 60 units. Six facilities will be managed by Meridian Senior Living and seven will be managed by Saber Healthcare Group, LLC.....Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.


Charted Territory
Even though it’s a short month, February saw a good bit of M&A activity with some sizable prices. Here are the top 10 biggest deals of February 2013. Be sure to check out our April issue of The Health Care M&A Monthly, when we present our preliminary data on Q1:2013 mergers and acquisitions.


Top 10 Health Care Transactions in February 2013




Rights to Tysabri

Biogen Idec, Inc.



Cardinal Health, Inc.


Agila Specialties Private Limited

Mylan, Inc.


Assisted Living Concepts, Inc.




Radiometer Medical ApS


Rosemont Pharmaceuticals Ltd.

Perrigo Company


Rights to Octreolin

Roche Holding AG


Two skilled nursing facilities

AdCare Property Holdings, Inc.


Rights to ALN-PCS

The Medicines Company


Two senior apartment communities

Care Investment Trust Inc.


Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today


Technology Deal of the Week
SARcode Bioscience Inc. shareholders aren’t shedding any tears over the company’s acquisition by Shire plc. The deal includes an upfront payment of $160 million and additional, undisclosed milestone payments. SARcode attracted Shire’s attention with its Phase 3 compound, lifitegrast, now under development for the signs and symptoms of dry eye disease. Shire anticipates launching Lifitegrast in the United States as early as 2016, depending on the outcome of the Phase 3 program and FDA approval. Some 25 million Americans suffer from dry eye disease, and many more with symptoms—one of the most common complaints to eye care specialists.....Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.


In the Pipeline
Hepatitis C doesn’t excite anyone except investors, it seems. Enanta Pharmaceuticals is hoping its pipeline of products, led by ABT-450, a critical piece of AbbVie’s Phase 3 hepatitis C program, will excite investors enough to pay $14 to $16 apiece for 4 million shares in the company. The IPO, valued at $73 million, will provide enough cash to fund Enanta, even as it gathered $189 million in partnership cash and venture funds, according to its S-1 filing. Shares will be traded as NASDAQ: ENTA....Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.


NEW - The Health Care Services Acquisition Report, 19th Edition - Save $50
Deals have been made. The 2013 Health Care Services Acquisition Report contains private deals in this market that are too small to make it into the financial press. Take advantage of our limited time $50 instant savings offer - order The 2013 Health Care Services Acquisition Report by April 30th and receive $50 off your purchase! Now that’s a recession resistant deal. Go to or call 800-248-1668 to preorder today!


Upcoming Interactive M&A Webcast:
Hospitals: Buying, Selling and Valuing
Thursday, April 25, 2013, 1:00 pm ET            
The dramatic increase in Hospital M&A activity from 2010 through 2012 accounts for a 25% increase in the number of deals made compared to the prior three-year period. That steep incline in hospital mergers and acquisitions is expected to continue in the coming years. Find out more from our expert panel: David Ertel (Moderator), Chief Financial Officer, Einstein Healthcare Network; Arnie Kimmel, Senior Vice President of Development, Prime Healthcare Services; Joseph Lupica, Chairman, Newpoint Health; and Jim Moloney, Managing Director / Co-Head of Tax-Exempt M&A, Cain Brothers.
Go to or call 800-248-1668 to register.


Conference Calendar...Click here to see more